Selective cell therapy for the treatment of renal failure
AssigneeWake Forest University Health Sciences
InventorsAnthony Atala, James J. Yoo
Life of this patent
Estimating the term…
Loading patent…
AssigneeWake Forest University Health Sciences
InventorsAnthony Atala, James J. Yoo
Estimating the term…
Provided herein are isolated populations of kidney cells harvested from differentiated cells of the kidney, wherein cells have been expanded in vitro. The kidney cells may include peritubular interstitial cells of the kidney, and preferably produce erythropoietin (EPO). The kidney cells may also be selected based upon EPO production. Methods of producing an isolated population of EPO producing cells are also provided, and methods of treating a kidney disease resulting in decreased EPO production in a patient in need thereof are provided, including administering the population to the patient, whereby the cells produce EPO in vivo.
An isolated population of cells comprising differentiated peritubular interstitial cells harvested from kidney tissue and passaged in vitro.
A method of producing an isolated population of EPO producing cells, said method comprising the steps of:
A method of treating a kidney disease resulting in decreased EPO production in a patient in need thereof, said method comprising:
An isolated population of cells comprising differentiated human kidney cells harvested from human kidney tissue and passaged in vitro.
Dependencies are inferred from the claim text.